Chapter 21. Imaging organelle transport in primary hippocampal neurons treated with amyloid- beta oligomers

We describe a strategy for fluorescent imaging of organelle transport in primary hippocampal neurons treated with amyloid- beta (A beta ) peptides that cause Alzheimer's disease (AD). This method enables careful, rigorous analyses of axonal transport defects, which are implicated in AD and othe...

Full description

Saved in:
Bibliographic Details
Published inMethods in cell biology Vol. 131; pp. 425 - 451
Main Authors Gan, Kathlyn J, Silverman, Michael A
Format Journal Article
LanguageEnglish
Published 01.01.2016
Online AccessGet full text

Cover

Loading…
More Information
Summary:We describe a strategy for fluorescent imaging of organelle transport in primary hippocampal neurons treated with amyloid- beta (A beta ) peptides that cause Alzheimer's disease (AD). This method enables careful, rigorous analyses of axonal transport defects, which are implicated in AD and other neurodegenerative diseases. Moreover, we present and emphasize guidelines for investigating A beta -induced mechanisms of axonal transport disruption in the absence of nonspecific, irreversible cellular toxicity. This approach should be accessible to most laboratories equipped with cell culture facilities and a standard fluorescent microscope and may be adapted to other cell types.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-2
ISSN:0091-679X
DOI:10.1016/bs.mcb.2015.06.012